Attention-deficit/hyperactivity disorder medication switching for patients with aggression or mood changes secondary to current medication a review of clinical effectiveness and guidelines
The purpose of this report is to identify the clinical effectiveness, safety, and evidence-based guidelines regarding switching medications in patients with ADHD who experience aggression or mood changes secondary to treatment with common first-line pharmacological treatments
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Ottawa]
Canadian Agency for Drugs and Technologies in Health
2015, 14 September 2015
|
| Series: | Rapid response report : summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The purpose of this report is to identify the clinical effectiveness, safety, and evidence-based guidelines regarding switching medications in patients with ADHD who experience aggression or mood changes secondary to treatment with common first-line pharmacological treatments |
|---|---|
| Item Description: | Title from PDF caption |
| Physical Description: | 1 PDF file (14 pages) illustration |